A Partially Blinded Randomized Clinical Trial to Study the Immunogenicity and Safety of Intradermal Administration of ZOSTAVAX (V211).
Phase of Trial: Phase I
Latest Information Update: 30 Jun 2014
At a glance
- Drugs Varicella zoster virus vaccine live (Primary) ; Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Merck Sharp & Dohme
- 20 Feb 2013 Planned end date changed from 1 Sep 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 27 Nov 2012 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 27 Nov 2012 Planned End Date changed from 1 May 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.